The National Women’s Health Network Launches the 4Her2024 Get Out the Vote Campaign
Starting today, those who sign up for Voter Empowerment Alerts will get a free sticker designed by Sarah Epperson (while supplies last).
Relief in Supreme Court Ruling on Mifepristone Case
The Supreme Court ruled that the plaintiffs do not have standing in the case and the FDA regulations will remain unchanged.
What You Need to Know About the Alliance for Hippocratic Medicine v. FDA Supreme Court Case
If Congress passes the funding levels proposed by the House, as many as 2 million eligible parents and children would be turned away from the Women, Infants and Children (WIC) program.
Everything You Need to Know About Mifepristone, Medication Abortion Access, and the Case Working Its Way Through the Courts Right Now
~~~
The NWHN is Disappointed in the 5th Circuit Court’s Decision Regarding Mifepristone
Although the 5th Circuit Court’s decision does not go as far as anti-abortion advocates might have hoped, it is still a grave threat to abortion access.
The NWHN Applauds the FDA’s Decision to Make a Birth Control Pill Available Over-the-Counter
OPill is the first over-the-counter birth control pill available in the U.S. It is safe, effective, and will increase access to contraception for millions of women nationwide.
020: How the FDA Works and How Advocates Work With It with Kirsten Moore
---
The NWHN’s Written Testimony to the FDA Regarding Over-The-Counter Authorization of Opill, an Oral Contraceptive
Read the NWHN's testimony to the FDA in support of OPILL, an oral contraceptive, being approved for over-the-counter dispensation.
A Statement on the Supreme Court’s Mifepristone Decision
The National Women’s Health Network applauds the Supreme Court for its decision to block the lower court’s ruling against Mifepristone, one of two medication abortion drugs, until the end of the legal proceedings.